Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC–IV ovarian cancer-Reference-Cited by-同舟云学术

Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC–IV ovarian cancer

Published:2019 Issue:2 Volume:30 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Tozzi Roberto¹^ORCID,Casarin Jvan¹^ORCID,Baysal Ahmet¹^ORCID,Valenti Gaetano¹^ORCID,Kilic Yakup¹^ORCID,Majd Hooman Soleymani¹^ORCID,Morotti Matteo¹^ORCID

Affiliation:

1. Department of Gynaecologic Oncology, Nuffield Department of Women and Reproductive Health, University of Oxford, Oxford, United Kingdom.

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://synapse.koreamed.org/pdf/10.3802/jgo.2019.30.e25

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peritonectomy and resection of mesentery during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer: A phase I-II trial;European Journal of Surgical Oncology;2024-02

2. Feasibility of laparoscopic Visceral-Peritoneal Debulking (L-VPD) in patients with stage III-IV ovarian cancer: the ULTRA-LAP trial pilot study;Journal of Gynecologic Oncology;2024

3. Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study;Gynecologic Oncology;2023-12

4. Neo-adjuvant chemotherapy does not reduce surgical complexity nor the accuracy of intra-operative visual assessment of disease in advanced ovarian cancer;European Journal of Surgical Oncology;2023-11

5. Evolutions in the management of advanced ovarian cancer;Gynecology and Pelvic Medicine;2023-06